#
|
Entity
|
Type
|
Relation
|
Support
|
Relative specificity
|
1
|
Malignant neoplasm of breast
|
Disease
|
Known
|
Explain
|
|
2
|
AKT1 gene
|
Gene
|
Known
|
Explain
|
|
3
|
ESR1 gene
|
Gene
|
Known
|
Explain
|
|
4
|
ESR2 gene
|
Gene
|
Inferred
|
Explain
|
|
5
|
N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine
|
Compound
|
Inferred
|
Explain
|
|
6
|
4-hydroxyestradiol-17 alpha
|
Compound
|
Inferred
|
Explain
|
|
7
|
EHT 1864
|
Compound
|
Inferred
|
Explain
|
|
8
|
GW 7604
|
Compound
|
Inferred
|
Explain
|
|
9
|
TCL1B gene
|
Gene
|
Inferred
|
Explain
|
|
10
|
ERA-923
|
Compound
|
Inferred
|
Explain
|
|
11
|
Mammary Neoplasms, Experimental
|
Disease
|
Inferred
|
Explain
|
|
12
|
LY 353381
|
Compound
|
Inferred
|
Explain
|
|
13
|
PGR gene
|
Gene
|
Inferred
|
Explain
|
|
14
|
CCI 779
|
Compound
|
Inferred
|
Explain
|
|
15
|
AR gene
|
Gene
|
Inferred
|
Explain
|
|
16
|
beta-hexachlorocyclohexane
|
Compound
|
Inferred
|
Explain
|
|
17
|
2,3-bis(3'-hydroxybenzyl)butyrolactone
|
Compound
|
Inferred
|
Explain
|
|
18
|
equol
|
Compound
|
Inferred
|
Explain
|
|
19
|
Heptachlor Epoxide
|
Compound
|
Inferred
|
Explain
|
|
20
|
Linseed Oil
|
Compound
|
Inferred
|
Explain
|
|
21
|
PPARGC1B gene
|
Gene
|
Inferred
|
Explain
|
|
22
|
4-(1H-imidazol-1-yl)retinoic acid
|
Compound
|
Inferred
|
Explain
|
|
23
|
Goserelin
|
Compound
|
Inferred
|
Explain
|
|
24
|
indium phosphide
|
Compound
|
Inferred
|
Explain
|
|
25
|
CDEC
|
Compound
|
Inferred
|
Explain
|
|
26
|
N-((4-hydroxyphenyl)retinamide)-O-glucuronide
|
Compound
|
Inferred
|
Explain
|
|
27
|
2,4-diaminotoluene
|
Compound
|
Inferred
|
Explain
|
|
28
|
tyrphostin AG 1024
|
Compound
|
Inferred
|
Explain
|
|
29
|
BCAR4 gene
|
Gene
|
Inferred
|
Explain
|
|
30
|
1,2,3-trichloropropane
|
Compound
|
Inferred
|
Explain
|
|
31
|
5-(1-aziridinyl)-2,4-dinitrobenzamide
|
Compound
|
Inferred
|
Explain
|
|
32
|
16-hydroxyestrone
|
Compound
|
Inferred
|
Explain
|
|
33
|
BRCATA protein
|
Compound
|
Inferred
|
Explain
|
|
34
|
Apigenin
|
Compound
|
Inferred
|
Explain
|
|
35
|
8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid
|
Compound
|
Inferred
|
Explain
|
|
36
|
2-hydroxyestradiol
|
Compound
|
Inferred
|
Explain
|
|
37
|
2-toluidine
|
Compound
|
Inferred
|
Explain
|
|
38
|
cyclophosphamide/doxorubicin/fluorouracil protocol
|
Other
|
Inferred
|
Explain
|
|
39
|
CEF regimen
|
Other
|
Inferred
|
Explain
|
|
40
|
AN-7 phosphate cpd
|
Compound
|
Inferred
|
Explain
|
|
41
|
2,6-diisocyanatotoluene
|
Compound
|
Inferred
|
Explain
|
|
42
|
nitromethane
|
Compound
|
Inferred
|
Explain
|
|
43
|
KF9-A
|
Compound
|
Inferred
|
Explain
|
|
44
|
LY 117018
|
Compound
|
Inferred
|
Explain
|
|
45
|
CB 403
|
Compound
|
Inferred
|
Explain
|
|
46
|
pararosaniline
|
Compound
|
Inferred
|
Explain
|
|
47
|
CMF regimen
|
Other
|
Inferred
|
Explain
|
|
48
|
2,3-bis(3'-hydroxybenzyl)butane-1,4-diol
|
Compound
|
Inferred
|
Explain
|
|
49
|
nitric-oxide synthase regulator activity
|
Function
|
Inferred
|
Explain
|
|
50
|
deguelin
|
Compound
|
Inferred
|
Explain
|
|
51
|
FAM19A4 gene
|
Gene
|
Inferred
|
Explain
|
|
52
|
2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene
|
Compound
|
Inferred
|
Explain
|
|
53
|
5-nitroacenaphthene
|
Compound
|
Inferred
|
Explain
|
|
54
|
Methylene Chloride
|
Compound
|
Inferred
|
Explain
|
|
55
|
kaempferol
|
Compound
|
Inferred
|
Explain
|
|
56
|
4-methoxy-3-phenylenediamine
|
Compound
|
Inferred
|
Explain
|
|
57
|
SDZ PSC 833
|
Compound
|
Inferred
|
Explain
|
|
58
|
Toremifene
|
Compound
|
Inferred
|
Explain
|
|
59
|
ZD-1033
|
Compound
|
Inferred
|
Explain
|
|
60
|
Anthracenes
|
Compound
|
Inferred
|
Explain
|
|
61
|
ZD4054
|
Compound
|
Inferred
|
Explain
|
|
62
|
TMEM25 gene
|
Gene
|
Inferred
|
Explain
|
|
63
|
Procarbazine
|
Compound
|
Inferred
|
Explain
|
|
64
|
CI1033
|
Compound
|
Inferred
|
Explain
|
|
65
|
allyl sulfide
|
Compound
|
Inferred
|
Explain
|
|
66
|
methyleugenol
|
Compound
|
Inferred
|
Explain
|
|
67
|
MKI67 gene
|
Gene
|
Inferred
|
Explain
|
|
68
|
MAPK1 gene
|
Gene
|
Inferred
|
Explain
|
|
69
|
aranoza
|
Compound
|
Inferred
|
Explain
|
|
70
|
Phytoestrogens
|
Compound
|
Inferred
|
Explain
|
|
71
|
vinorelbine
|
Compound
|
Inferred
|
Explain
|
|
72
|
hydrazobenzene
|
Compound
|
Inferred
|
Explain
|
|
73
|
PCDHGB6 gene
|
Gene
|
Inferred
|
Explain
|
|
74
|
MAPK3 gene
|
Gene
|
Inferred
|
Explain
|
|
75
|
1,2-dibromo-3-chloropropane
|
Compound
|
Inferred
|
Explain
|
|
76
|
CCND1 gene
|
Gene
|
Inferred
|
Explain
|
|
77
|
4-oxofenretinide
|
Compound
|
Inferred
|
Explain
|
|
78
|
isoprene
|
Compound
|
Inferred
|
Explain
|
|
79
|
Aromatase Inhibitors
|
Compound
|
Inferred
|
Explain
|
|
80
|
YBX1 gene
|
Gene
|
Inferred
|
Explain
|
|
81
|
ERBB2 gene
|
Gene
|
Inferred
|
Explain
|
|
82
|
2-methoxyestradiol-3,17-bis-O,O-sulfamate
|
Compound
|
Inferred
|
Explain
|
|
83
|
FEC protocol
|
Other
|
Inferred
|
Explain
|
|
84
|
Dichlorodiphenyl Dichloroethylene
|
Compound
|
Inferred
|
Explain
|
|
85
|
letrozole
|
Compound
|
Inferred
|
Explain
|
|
86
|
glycidol
|
Compound
|
Inferred
|
Explain
|
|
87
|
2-methoxyestradiol-3,17-O,O-bis(sulfamate)
|
Compound
|
Inferred
|
Explain
|
|
88
|
ZNF365 gene
|
Gene
|
Inferred
|
Explain
|
|
89
|
Organoselenium Compounds
|
Compound
|
Inferred
|
Explain
|
|
90
|
Heptachlor
|
Compound
|
Inferred
|
Explain
|
|
91
|
CYP19A1 gene
|
Gene
|
Inferred
|
Explain
|
|
92
|
TOX3 gene
|
Gene
|
Inferred
|
Explain
|
|
93
|
indole-3-carbinol
|
Compound
|
Inferred
|
Explain
|
|
94
|
2,2-bis(bromomethyl)-1,3-propanediol
|
Compound
|
Inferred
|
Explain
|
|
95
|
Dieldrin
|
Compound
|
Inferred
|
Explain
|
|
96
|
estrone sulfate
|
Compound
|
Inferred
|
Explain
|
|
97
|
Ethylene Oxide
|
Compound
|
Inferred
|
Explain
|
|
98
|
RSPO3 Gene
|
Gene
|
Inferred
|
Explain
|
|
99
|
Anthracyclines
|
Compound
|
Inferred
|
Explain
|
|
100
|
selenomethylselenocysteine
|
Compound
|
Inferred
|
Explain
|
|